Grow Group's Ben Langley and Grow Germany CEO Susan Noesbusch announced this week that their medical cannabis extract has been launched in Germany by Nimbus Health GmbH on the basis of a licensing trade agreement.
Nimbus is a pharmaceutical distributor that specialises in the distribution, registration, sales and marketing of medical cannabis in Germany.
Grow Group PLC is a biopharmaceutical company focused solely on cannabis-based medicines and improving global access to those medicines. The company seeks to be the world's leading supplier of medical cannabis to patients by 2025.